Prostaglandin A2 induces caspase-independent apoptosis in hepatocellular carcinoma cells
Related Experiment Video
Updated: Aug 18, 2026

Lighting Up the Pathways to Caspase Activation Using Bimolecular Fluorescence Complementation
Published on: March 5, 2018
Ho-Shik Kim1, Jae-Chun Shim, Ju-Youn Choi
1Department of Biochemistry, College of Medicine, The Catholic University of Korea, Seoul, Korea.
Background/Aims:
Prostaglandin (PG) A2 has been reported to inhibit the growth of hepatocellular carcinoma cells via activation of apoptosis, although the molecular mechanisms involved have not been clarified, yet. To investigate the mechanism of the PGA2-induced apoptosis, we analyzed the activation of caspases during the apoptosis of hepatoma cell lines.
Methods:
Induction of apoptosis by PGA2 in hepatoma cell lines, Hep 3B and Hep G2, was assessed by DAPI staining of nuclei and agarose gel electrophoresis of genomic DNA. The involvement of caspases was analyzed by immunoblot analysis of poly ADP-ribose polymerase (PARP) and by checking the effect of caspase inhibitors on PGA2-induced apoptosis.
Results:
PGA2 inhibited the growth of Hep 3B and Hep G2 cells, accompanying nuclear condensation and fragmentation, and genomic DNA laddering, which are the hallmarks of apoptosis. The PARP was not cleaved during the apoptosis of Hep 3B and Hep G2 cells and caspase inhibitors such as z-VAD-Fmk and z-DEVD-Fmk exerted no effect on the PGA2-induced apoptosis.
Conclusions:
These results suggest that PGA2 induces apoptosis in Hep 3B and Hep G2 cells via caspase-independent pathway.
Insights
Prostaglandin A2 (PGA2) inhibits hepatocellular carcinoma cell growth through apoptosis. This study reveals PGA2 triggers apoptosis via a caspase-independent pathway, not involving PARP cleavage.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Hepatocellular carcinoma (HCC) is a major global health concern.
- Prostaglandin A2 (PGA2) shows potential in inhibiting HCC growth.
- The precise molecular mechanisms of PGA2-induced apoptosis in HCC remain unclear.
Purpose of the Study:
- To elucidate the molecular mechanisms underlying PGA2-induced apoptosis in hepatoma cell lines.
- To investigate the role of caspases in PGA2-mediated apoptosis of liver cancer cells.
Main Methods:
- Hepatoma cell lines (Hep 3B, Hep G2) were treated with PGA2.
- Apoptosis was assessed using DAPI staining and DNA fragmentation analysis.
- Caspase involvement was evaluated through Western blot for PARP cleavage and functional assays with caspase inhibitors.
Main Results:
- PGA2 induced apoptosis in Hep 3B and Hep G2 cells, evidenced by nuclear condensation, fragmentation, and DNA laddering.
- Poly ADP-ribose polymerase (PARP) was not cleaved during PGA2-induced apoptosis.
- Caspase inhibitors (z-VAD-Fmk, z-DEVD-Fmk) did not affect PGA2-induced apoptosis.
Conclusions:
- PGA2 induces apoptosis in hepatocellular carcinoma cells.
- The apoptosis triggered by PGA2 in these cells operates through a caspase-independent pathway.
Related Concept Videos
Caspases
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway
Apoptosis
Cellular Injury V: Apoptosis and Autophagy
Phagocytosis of Apoptotic Cells
Normal cells contain receptors that prevent them from being recognized by phagocytes.